1997-2021 Partner Retina-Vitreous Associates of Florida, Clearwater, FL.
2014-2021 Vice-President Drug Delivery Company, LLC
2012-2021 President Retina Gallery, LLC
2009-2021 Clinical Professor of Ophthalmology
University of South Florida, Tampa, FL.
1994-1996 Associate Retina Associates of Florida, Clearwater, FL.
EDUCATION AND TRAINING
1993-1994 FellowBascom Palmer Eye Institute, Miami, FL. Surgical retina fellowship.
1992-1993 FellowBascom Palmer Eye Institute, Miami, FL. Medical retina fellowship.
1989-1992 ResidentUniversity of California, Davis, Department of Ophthalmology, Sacramento, CA.
1988-1989 Intern Transitional Program, The Miriam Hospital, Brown University, Providence, RI.
1984-1988 StudentHarvard Medical School, Boston, MA. M.D. in Hematology-Oncology, Graduated from the Harvard-M.I.T. Division of Health Sciences and Technology. Graduate thesis Vitamin D and Retinoblastoma.
1980-1984 StudentHarvard College, Cambridge, MA. B.A. in Applied Mathematics with Honors.
May, 2014 American Board of Ophthalmology (re-certification)
May, 2004 American Board of Ophthalmology (re-certification)
May, 1994 American Board of Ophthalmology
A bioresorbable drug eluting intravitreal implant system includes a syringe with a chamber containing a medicinal drug. A balloon is releasably secured to a needle where the needle has a central section chamber in fluid communication with a chamber in the syringe. The needle central section has an opening formed through a wall for transporting the medicinal drug to the interior of the balloon subsequent to insertion of the needle through the sclera of a patient's eye.
2013 - 2021 Elected by his peers for inclusion in Best Doctors in America®
2013-2021 Most Compassionate Doctor - Vitals American Registry
2014-2021 Castle Connoly Best Doctor (US News and World Report)
2015 Honor Award - American Academy of Ophthalmology
2011 David D. Donaldson Clinical Faculty Teaching Award USF
2009-2010 President – Tampa Bay Ophthalmological Society
1987 Lion's Ophthalmic Research Fellowship
1984 Kirkland House Master's Award
1981-1984 Harvard Scholarship
1980 Bausch and Lomb Medal for Science Achievement
1979 High Honors, A Model of the Universe: The expansion of which is attributed to a force exerted by space. Presented at the Science Teachers Association of New York State, May 18, 1979. The existence of this expansile force has been verified and it is now known as Dark Energy.
2003-2021 Preceptor, Longitudinal Clinical Experience, University of South Florida. One half day weekly a first or second year student spends time in my office seeing and discussing patients in my private retina clinic.
1994-2021 Preceptor, Fluorescein Conference, All Children's Hospital, St. Petersburg, FL. First Friday of each month, all ophthalmology residents, teaching conference. Present and discuss photograph and fluorescein angiograms from interesting retinal cases from clinical practice.
1994-2021 Lecturer, Resident morning conference, University of South Florida Department of Ophthalmology morning conference once or twice yearly. One to 2 hour lecture on retina topic for all ophthalmology residents.
1994-1996 Attending, Resident VA Hospital and All Children's Hospital retina clinic, four times yearly at either VA Hospital in Tampa or All Children's Hospital. Half day as attending of resident clinic.
Archives of Ophthalmology, American Journal of Ophthalmology, Retina, Expert Review of Ophthalmology (New Journal)
1990-2021 American Academy of Ophthalmology
1986-2021 American Medical Association
1996-2021 American Society of Retinal Specialists (aka Vitreous Society)
1994-2021 Tampa Bay Ophthalmic Society
1994-2021 Florida Medical Society
1994-2021 Florida Society of Ophthalmology
1999-2010 American Association for the Advancement of Science
1994-2006 Pinellas County Medical Society
1996-2005 American Diabetes Association
1995-2005 Nantucket Retina Society
1989-2003 Association for Research in Vision and Ophthalmology
1989-1992 Contact Lens Association of Ophthalmologists
1989-1992 California Association of Ophthalmology
1989-1992 Alta, Northern California Ophthalmic Society
1989-1991 California Medical Association
1986-1990 Massachusetts Medical Society
Largo Hospital, St. Anthony's Hospital, All Children's Hospital, and Countryside Surgery Center
2014-2021 TOGA: Treatment with Oracea for Geographic Atrophy: Phase II/III Study Evaluating the Safety and Efficacy of daily oral administration of doxycycline (ORACEA) vs placebo in subjects with GA, Investigator.
2014-2021 Ophthotech Protocol OPH1004A: A Phase 3 Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista (Anti PDGF-B Pegylated Aptamer) Administered in Combination with Either Avastin or Eylea Monotherapy in Subjects with Neovascular Age-Related Macular Degeneration, Investigator.
2014-2021 Thrombogenics Protocol TG-MV-018: Ocriplasmin Research to Better Inform Treatment (ORBIT) Phase 4 Trial, Investigator.
2014-2021 Genentech/Roche Protocol GX29185: A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration, Investigator.
NATIONAL INSTITUTE OF HEALTH (NIH) STUDIES
1992-1994 Study of the Ocular Complications of AIDS (SOCA)
1992-1994 Collaborative Ocular Melanoma Study (COMS)
2005-2007 Diabetic Retinopathy Clinical Research Network (DRCRnet)
Collaborative Ocular Melanoma Study Group. The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS report no. 18. Arch Ophthalmol 2001;119:969-982.
Collaborative Ocular Melanoma Study Group. The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS report no. 17. Arch Ophthalmol 2001;119:951-965.
Cohen SM. Intraocular Adjuvants, Macular Hole Surgery, and Endophthalmitis. Vitreous society on line journal, 1997 June;1(1):[10 screens]. Available from: URL:http://www.vitreoussociety.org/journal/origin/cohen/machol17.htm
Lewis ML, Cohen SM, Smiddy WE, Gass JDM. Bilaterality of macular holes. Graefe's Arch Clin Exp Ophthalmol 1996;234:241-5.
Studies of Ocular Complications of AIDS in collaboration with the AIDS Clinical Trials Group: Assessment of cytomegalovirus retinitis: clinical evaluation versus centralized grading of fundus photographs. Arch Ophthalmol 1996;114:791-805
Studies of Ocular Complications of AIDS in collaboration with the AIDS Clinical Trials Group: Clinical vs. photographic assessment of treatment of cytomegalovirus retinitis. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Arch Ophthalmol 1996;114:848-855.
Wells CG, Bradford RH, Fish GE, Straatsma BR, Hawkins BS, and COMS group. Choroidal melanomas in American Indians. Arch Ophthalmol 1996;114:1017-8.
Pautler SE, Cohen SM, Findlay KB, Eichenbaum DA, Lopez M. Clinical findings of the posterior uveal effusion syndrome. American Academy of Ophthalmology. 2015 Annual Meeting. Abstract ID 30043320. Poster Presentation PO476
Eichenbaum D, Cohen S, Billiris-Findlay, K. “Monthly Versus Treat-and-Extend Ranibizumab for Center-Involving Diabetic Macular Edema: a Prospective Randomized Investigator-Sponsored Trial,” Club Vit, July 1, 2014.
Eichenbaum D, Cohen S, Billiris-Findlay, K. “Monthly Versus Treat-and-Extend Ranibizumab for Center-Involving Diabetic Macular Edema: a Prospective Randomized Investigator-Sponsored Trial,” American Society of Retinal Specialists, August 11, 2014.
Cohen SM. Infrared Reflectance and Spectral Domain OCT Findings Following Pneumatic Retinopexy. Chicago: Annual Meeting of the American Academy of Ophthalmology, October 2014.
Prabakaran S, Cohen SM. Patients undergoing treatment for wet age-related macular degeneration in one eye rarely present for an unscheduled emergent office visit when they develop wet AMD in their second eye. Orlando, ARVO May 2014.
Cohen SM, Muller LT, Espana EM, Behler SC. An Outbreak of Mycobacterium Abscessus Nodular Scleritis Following Intravitreal Injection. New Orleans, Annual Meeting of the American Academy of Ophthalmology, October 2013.
Eichenbaum D, Cohen S, Pautler S, Billiris-Findlay K. A Prospective Study of Ranibizumab for DME: Monthly injections vs Treat-and-Extend. Toronto: American Society of Retinal Specialists, August 2013.
Malavade SS, Cohen SM. Optimal treatment strategy for Stage 5 Type 2A Idiopathic Macular Telangiectasia with anti-vascular endothelial growth factor (VEGF) agents - When to stop?
Seattle, ARVO May, 2013.
Cohen SM. Macular Hole in Group 2a Juxtafoveal Retinal Telangiectasis. Gass Society Meeting. 2010. Vancouver, August 2010.
Cohen SM. The Risk of Subsequent Retinal Tears in Eyes with Acute Posterior Vitreous Detachment and Vitreous Hemorrhage. Annual Meeting of the American Society of Retinal Specialists, Vancouver, August 2010.
Kay CN, Cohen SM, Pavan PR, Small L. Prevalence of familial trends in a population with macular holes. American Society of Retinal Specialists, New York 2009.
Cohen SM. Natural History of Asymptomatic, Clinical Retinal Detachment. Ophthalmology (Supplement) 2004;225.
Elliot J, Pautler SE, Cohen SM. Pain following retina and vitreous surgery. Ophthalmology (Supplement) 2004;238.
Cukrowski C, Cohen SM. Cystoid Macular Edema Following Pars Plana Vitrectomy for Retained Lens. Ophthalmology (Supplement) 2001;108:262.
Cohen SM. Central retinal vein occlusion in diabetics. Vitreous Society Meeting, Cancun, Mexico, 2000.
Cohen SM. Natural History of Asymptomatic Retinal Detachment. Vitreous Society Meeting, Cancun, Mexico, 2000.
Cohen SM, Han DP, Johnson MW, Gass JDM. Foveal retinoschisis in females. Ophthalmology (supplement) 1996;103:185.
Cohen SM, Hammer ME, Grizzard WS. Endophthalmitis after pars plana vitrectomy with or without autologous blood products for macular hole. Ophthalmology (supplement) 1996;103:161.
Ormerod LD, Cohen SM, Davis JL. New Retinal and Choroidal Manifestations of Cat Scratch Disease. Invest Ophthalmol Vis Sci 1995;36:782
Cohen SM, Weishaar PD, Murray TG. Effects of Photocoagulation on Laser Power Transmission Through Human Retina. Invest Ophthalmol Vis Sci 1995;36:833
Hammer ME, Cohen SM, Grizzard WS. Vitrectomy to treat Macular Holes: The Learning Curve. Invest Ophthalmol Vis Sci 1995;36:1050
Lewis ML, Cohen SM, Smiddy WE, Gass JDM. Bilaterality of macular holes. Biannual Meeting of the Club Jules Gonin, Versailles, France, September 9-13, 1994.
Cohen SM, Shen JH, Ren Q, Smiddy WE. Argon, krypton and diode laser transmission through blood. Invest Ophthalmol Vis Sci 1994;35:1750.
Flynn HW, Jr., Cohen SM, Miller D. Endophthalmitis caused by Serratia marcescens. Invest Ophthalmol Vis Sci 1994;35:1993.
Cohen SM, Grajewski AL, Gass JDM, Palmberg PF, Flynn HW, Jr. Treatment of post-trabeculectomy hypotony maculopathy. Ophthalmology (supplement) 1993;100:98.
Callanan D, Davis JL, Cohen SM, Halperin L, Gass JDM. The use of ivermectin in diffuse unilateral subacute neuroretinitis. Ophthalmology (supplement) 1993;100:114.
Gass JDM, Cohen SM. Subretinal fibrosis in multifocal choroiditis. Annual Meeting of the Eastern Ophthalmic Pathology Society, Jekyl Island, Georgia, October 9-11, 1992.
Benner JD, Cohen SM, Landers MB, Morse LS. Intraoperative posterior chamber cultures from vitrectomized patients. Invest Ophthalmol Vis Sci 1992;33:1056.
Cohen SM, Olin KL, Keen CL, Sousa FJ, Morse LS. Antioxidants and trace element analysis in patients with age-related macular degeneration. Ophthalmology (supplement) 1991;98:123.
Cohen SM, Brandt JD, Sousa FJ, Gulyassy P. Ocular hypertensive effect of hemodialysis. Ophthalmology (supplement) 1991;98:109.
Cohen SM, Olin KL, Morse LS, Murphy C, Toth C, Line S, Bellhorn R , Hjelmeland L, Keen CL. Antioxidants and trace element analysis in monkeys and humans with age-related macular degeneration. Invest Ophthalmol Vis Sci 1990;31:356.
Cohen SM, Sullivan C, Albert DM. Effect of sodium butyrate on human Y-79 xenografts in athymic mice. Invest Ophthalmol Vis Sci 1988;29:340.